As Indian pharmaceutical companies begin rolling out generic versions of semaglutide, a drug commonly prescribed for type 2 diabetes and obesity, patients are increasingly seeking it for weight loss rather than its intended medical use.
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
